This presentation will explore severe keratitis from dry eye disease and the outcomes from the real-world PERSPECTIVE study of Ikervis (ciclosporin 1mg/ml). It will cover diagnosis and treatment options for the condition (including Ikervis), as well as present results from the PERSPECTIVE study and discuss insights which may be applied in an Australian clinical practice setting. The webinar will include practical guidance and case studies to aid in learning.
Learning Objectives:
- Identify patients with severe keratitis from dry eye disease.
- Choose the most appropriate treatment option for individual patients.
- Recall the key outcomes from the real-world PERSPECTIVE study.
- Describe the correct use of Ikervis in eligible patients, including the prescribing process.
